Murray J. B. Brown

4.0k total citations · 1 hit paper
41 papers, 3.2k citations indexed

About

Murray J. B. Brown is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Murray J. B. Brown has authored 41 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Murray J. B. Brown's work include Enzyme Catalysis and Immobilization (8 papers), RNA and protein synthesis mechanisms (7 papers) and Microbial Natural Products and Biosynthesis (5 papers). Murray J. B. Brown is often cited by papers focused on Enzyme Catalysis and Immobilization (8 papers), RNA and protein synthesis mechanisms (7 papers) and Microbial Natural Products and Biosynthesis (5 papers). Murray J. B. Brown collaborates with scholars based in United Kingdom, United States and Ireland. Murray J. B. Brown's co-authors include Alastair D. Reith, James Staunton, Jesús Cortés, Peter F. Leadlay, Paul S. Carter, Ainsley A. Culbert, David G. Smith, Gheorghe‐Doru Roiban, Darren A.E. Cross and Richard C. Lloyd and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Murray J. B. Brown

40 papers receiving 3.2k citations

Hit Papers

Selective small molecule inhibitors of glycogen synthase ... 2000 2026 2008 2017 2000 250 500 750

Peers

Murray J. B. Brown
Jef K. De Brabander United States
Rodolfo Márquez United Kingdom
Donald S. Karanewsky United States
Ian P. Street Australia
Shailaja Kasibhatla United States
Michelle F. Browner United States
Kathryn M. Koeller United States
Haitao Ji United States
Bin Qin China
Murray J. B. Brown
Citations per year, relative to Murray J. B. Brown Murray J. B. Brown (= 1×) peers György Dormán

Countries citing papers authored by Murray J. B. Brown

Since Specialization
Citations

This map shows the geographic impact of Murray J. B. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray J. B. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray J. B. Brown more than expected).

Fields of papers citing papers by Murray J. B. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray J. B. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray J. B. Brown. The network helps show where Murray J. B. Brown may publish in the future.

Co-authorship network of co-authors of Murray J. B. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Murray J. B. Brown. A scholar is included among the top collaborators of Murray J. B. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray J. B. Brown. Murray J. B. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Fei, J. Domenech, Murray J. B. Brown, et al.. (2025). Engineered Biocatalyst for Enantioselective Hydrazone Reduction. Angewandte Chemie International Edition. 64(26). e202424350–e202424350.
2.
Burke, Ashleigh J., Thomas M. Lister, James R. Marshall, et al.. (2023). Engineered Biocatalysts for Enantioselective Reductive Aminations of Cyclic Secondary Amines. ChemCatChem. 15(11). 10 indexed citations
3.
Schroeder, Courtney M., Trevor D. Littlewood, Murray J. B. Brown, et al.. (2022). Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK. Journal of Biological Chemistry. 298(6). 101916–101916. 6 indexed citations
4.
Adams, Joseph P., Murray J. B. Brown, Alba Díaz‐Rodríguez, Richard C. Lloyd, & Gheorghe‐Doru Roiban. (2019). Biocatalysis: A Pharma Perspective. Advanced Synthesis & Catalysis. 361(11). 2421–2432. 169 indexed citations
5.
Christopher, J.A., Francis Atkinson, B.D. Bax, et al.. (2009). 1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3. Bioorganic & Medicinal Chemistry Letters. 19(8). 2230–2234. 29 indexed citations
6.
Takle, Andrew K., Murray J. B. Brown, Susannah Davies, et al.. (2005). The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 16(2). 378–381. 170 indexed citations
7.
Smith, Kathrine J., Paul S. Carter, Angela Bridges, et al.. (2004). The Structure of MSK1 Reveals a Novel Autoinhibitory Conformation for a Dual Kinase Protein. Structure. 12(6). 1067–1077. 41 indexed citations
8.
Bruton, Gordon, Anthony Huxley, Peter J. O’Hanlon, et al.. (2003). Lipopeptide substrates for SpsB, the Staphylococcus aureus type I signal peptidase: design, conformation and conversion to α-ketoamide inhibitors. European Journal of Medicinal Chemistry. 38(4). 351–356. 47 indexed citations
9.
Bloomer, Jackie C., Murray J. B. Brown, Hung‐Yuan Cheng, et al.. (2003). The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 13(6). 1067–1070. 100 indexed citations
10.
Jarvest, Richard L., John M. Berge, Murray J. B. Brown, et al.. (2003). Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 13(4). 665–668. 32 indexed citations
11.
Bax, B.D., Paul S. Carter, Ceri Lewis, et al.. (2001). The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation. Structure. 9(12). 1143–1152. 172 indexed citations
12.
Brown, Murray J. B., et al.. (2001). Simple Absorbance-Based Assays for Ultra-High Throughput Screening. SLAS DISCOVERY. 6(1). 3–9. 25 indexed citations
13.
Turconi, Sandra, Stephen Ashman, David L. Earnshaw, et al.. (2001). Real Experiences of uHTS: A Prototypic 1536-Well Fluorescence Anisotropy-Based uHTS Screen and Application of Well-Level Quality Control Procedures. SLAS DISCOVERY. 6(5). 275–290. 39 indexed citations
14.
Culbert, Ainsley A., Murray J. B. Brown, Sheelagh Frame, et al.. (2001). GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity. FEBS Letters. 507(3). 288–294. 80 indexed citations
15.
Coghlan, Matthew P., Ainsley A. Culbert, Darren A.E. Cross, et al.. (2000). Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chemistry & Biology. 7(10). 793–803. 771 indexed citations breakdown →
16.
Pope, Andrew J., Keith J. M. Moore, Mary McVey, et al.. (1998). Characterization of Isoleucyl-tRNA Synthetase from Staphylococcus aureus. Journal of Biological Chemistry. 273(48). 31691–31701. 49 indexed citations
17.
Pope, Andrew J., Jacques Lapointe, Lucy Mensah, et al.. (1998). Characterization of Isoleucyl-tRNA Synthetase from Staphylococcus aureus. Journal of Biological Chemistry. 273(48). 31680–31690. 41 indexed citations
18.
Oliynyk, Markiyan, Murray J. B. Brown, Jesús Cortés, James Staunton, & Peter F. Leadlay. (1996). A hybrid modular polyketide synthase obtained by domain swapping. Chemistry & Biology. 3(10). 833–839. 145 indexed citations
19.
Cortés, Jesús, et al.. (1995). Polyketide synthesis in vitro on a modular polyketide synthase. Chemistry & Biology. 2(9). 583–589. 69 indexed citations
20.
Cortés, Jesús, et al.. (1995). Repositioning of a Domain in a Modular Polyketide Synthase to Promote Specific Chain Cleavage. Science. 268(5216). 1487–1489. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026